CCT137690, an inhibitor of both Aurora kinase A and B, inhibited cell proliferation in MYCN-amplified neuroblastoma cells and tumor growth in MYCN-driven transgenic tumors in vivo [127]. This evidence concerns the gene MYCN and neoplasm.